Effects of POH in Combination with STI571 on the Proliferation and Apoptosis of K562 Cells
The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry...
Saved in:
Published in | Current medical science Vol. 24; no. 1; pp. 41 - 44 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
China
Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022
2004
|
Subjects | |
Online Access | Get full text |
ISSN | 1672-0733 2096-5230 1993-1352 2523-899X |
DOI | 10.1007/BF02830702 |
Cover
Abstract | The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time and dosedependent manner with the inhibitory rate of 100 μmol/L POH on K562 cells at 36 h being (53.2±3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0. 256±0. 054) μmol/L. In a time and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0.2 μmol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that ofSTI571 (P~0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0.2 μmol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 μmol/L, 100 μmol/L, 200 μmol/L with 0.2 μmol/L STI571 could strongly induced apoptosis, es-pecially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells. |
---|---|
AbstractList | R3; Summary: The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dosedependent manner with the inhibitory rate of 100μmol/L POH on K562 cells at 36 h being (53.2±3.65) %. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36h was (0. 256±0. 054) μmol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0. 2 μmol/L STI571 had the same inhibitory effects on the K562cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of ST1571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0. 2 μmol/L STI571could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50μmol/L, 100 μmol/L, 200μmol/L with 0.2μmol/L STI571 could strongly induced apoptosis, especially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of ST1571 inhibiting the proliferation and inducing apoptosis of K562 cells. The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time and dosedependent manner with the inhibitory rate of 100 μmol/L POH on K562 cells at 36 h being (53.2±3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0. 256±0. 054) μmol/L. In a time and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 μmol/L POH at 40 h being (21.0±3.3)%. Both 100 μmo/L POH and 0.2 μmol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that ofSTI571 (P~0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0.2 μmol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 μmol/L, 100 μmol/L, 200 μmol/L with 0.2 μmol/L STI571 could strongly induced apoptosis, es-pecially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells. The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells. The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Bcr/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0 +/- 11.3 micromol/L and 113.6 +/- 23.4 micromol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 micromol/L POH on K562 cells at 36 h being (53.2 +/- 3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256 +/- 0.054) micromol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 micromol/L POH at 40 h being (21.0 +/- 3.3)%. Both 100 micromo/L POH and 0.2 micromol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 micromol/L, 100 micromol/L and 200 micromol/L POH in combination with 0.2 micromol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 micromol/L, 100 micromol/L, 200 micromol/L with 0.2 micromol/L STI571 could strongly induced apoptosis, especially 200 micromol/L POH in combination with 0.2 micromol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells. |
Author | 陈燕 胡东 |
AuthorAffiliation | InstituteofHematology,UnionHospital,TongjiMedicalCollege,HuazhongUniversityofScienceandTechnology,Wuhan430022 |
AuthorAffiliation_xml | – name: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022 |
Author_xml | – sequence: 1 fullname: 陈燕 胡东 |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/15165112$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc9vVCEQx4mpsT_04h9g8OJB85SBBd471k1rG5u0ifXihQAPumzfwhbYtP3vxe6qifE0M8lnvvOdmUO0F1N0CL0G8hEIkZ8-nxLaMyIJfYYOYBhYB4zTvZYLSTsiGdtHh6UsCeFS0NkLtA8cBAegB-jHiffO1oKTx1eXZzhEPE8rE6KuIUV8H-oCf7s-5xJwK-vC4aucpuBd3gI6jvh4ndY1lfAk8pULiudumspL9NzrqbhXu3iEvp-eXM_PuovLL-fz44vOwkCha4Y9B8usoNw2U6aXQIQ2ZhyNmxnrGUhte-24aOa5GxkdDKc9l7OejZawI_Rhq3uvo9fxRi3TJsc2UdXl4-348GCUo4TMCBCARr_b0uuc7jauVLUKxTa_Orq0KUrCwIde8Aa-2YEbs3KjWuew0vlR_b5dA8gWsDmVkp1XNtSnq9Ssw6SAqF_vUX_f01re_9PyR_V_8NsdvEjx5i60zYy2tz5MTg1MCME5-wnyCpZn |
CitedBy_id | crossref_primary_10_1155_2014_953451 |
Cites_doi | 10.1038/sj.leu.2401536 10.1182/blood.V96.10.3343 10.1182/blood.V97.7.2008 10.1093/jn/127.5.668 10.1093/jn/129.3.775S 10.1038/sj.leu.2402369 10.1182/blood.V96.9.3195 |
ClassificationCodes | R3 |
ContentType | Journal Article |
Copyright | Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
Copyright_xml | – notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved. |
DBID | 2RA 92L CQIGP W91 ~WA AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 2B. 4A8 92I 93N PSX TCJ |
DOI | 10.1007/BF02830702 |
DatabaseName | 维普期刊资源整合服务平台 中文科技期刊数据库-CALIS站点 中文科技期刊数据库-7.0平台 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Wanfang Data Journals - Hong Kong WANFANG Data Centre Wanfang Data Journals 万方数据期刊 - 香港版 China Online Journals (COJ) China Online Journals (COJ) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1993-1352 2523-899X |
EndPage | 44 |
ExternalDocumentID | tjykdxxb_e200401011 15165112 10_1007_BF02830702 9366655 |
Genre | Journal Article |
GroupedDBID | -5E -5G -BR -Y2 -~C .86 .VR 06C 06D 0R~ 0VY 1N0 29K 29~ 2B. 2C~ 2J2 2JN 2KG 2KM 2LR 2RA 2~H 30V 4.4 408 40D 40E 53G 5GY 5VS 6NX 8TC 8UJ 92F 92I 92L 95- 95. 95~ 96X AAAVM AABHQ AAJKR AANXM AARHV AARTL AAYIU AAYQN AAYTO ABFTV ABJOX ABKCH ABMNI ABNWP ABQBU ABTMW ACGFS ACHXU ACKNC ACOMO ACSNA ACUDM ADHIR ADINQ ADKPE ADURQ ADYFF ADZKW AEBTG AEGNC AEJHL AEKMD AEOHA AEPYU AETLH AEXYK AFWTZ AFZKB AGAYW AGDGC AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHYZX AIIXL AJBLW AJRNO ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP ARMRJ AZFZN B-. BA0 BGNMA CAG CCEZO CHBEP CIEJG COF CQIGP CS3 CSCUP CW9 D-I EBS EJD ESBYG FA0 FEDTE FNLPD FRRFC FWDCC G-Y G-Z GGCAI GGRSB GJIRD GQ6 GQ7 H13 HF~ HG6 HMJXF HRMNR HVGLF HZ~ IJ- IPNFZ IXD I~X I~Z J-C JBSCW JUIAU KOV M4Y MA- N2Q NDZJH NQJWS NU0 O9- O93 O9I O9J P9S PF0 QOR QOS R-E R89 R9I RIG ROL RPX RSV S.. S16 S1Z S27 S37 S3B SAP SCL SDH SHX SMD SNE SNX SOJ SPISZ SZ9 SZN T13 TCJ TGQ TSG TT1 TUC U2A U9L UG4 VC2 W48 W91 WK8 Z7U Z82 Z8V ZOVNA ~A9 ~WA -05 -0E -SE -S~ 2JY 406 5VR 92M 9D9 9DE AACDK AAHNG AAIAL AAJBT AANZL AAPKM AASML AATNV AAUYE AAYXX AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABHQN ABJNI ABKZE ABMQK ABSXP ABTEG ABTKH ABWNU ABXPI ACAOD ACDTI ACHSB ACMDZ ACMLO ACOKC ACSTC ACZOJ ADKNI ADRFC ADTPH AEFQL AEJRE AEMSY AESKC AEVLU AEZWR AFBBN AFDZB AFHIU AFLOW AFOHR AFQWF AFUIB AGJBK AGMZJ AGQEE AGRTI AHPBZ AHSBF AHWEU AIAKS AIGIU AILAN AITGF AIXLP AMXSW AMYLF AMYQR AOCGG ATHPR AXYYD AYFIA BDATZ CAJEE CITATION DDRTE DNIVK DPUIP EBLON EIOEI FERAY FFXSO FIGPU FINBP FSGXE GNWQR GRRUI IKXTQ IWAJR JZLTJ LLZTM NPVJJ PT4 Q-- RHV RT5 SCLPG SDE SISQX SJYHP SNPRN SOHCF SRMVM SSLCW STPWE T8U U1F U1G U5E U5O UOJIU UTJUX UZXMN VFIZW YLTOR ZMTXR ABQSL ADHKG CGR CUY CVF ECM EIF NPM 7X8 AGQPQ 4A8 93N PSX |
ID | FETCH-LOGICAL-c1921-199f51c3c625c511b87106abbddbe4bcf317ac8ae566245ed329b52857483dc03 |
ISSN | 1672-0733 2096-5230 |
IngestDate | Thu May 29 04:06:47 EDT 2025 Thu Jul 10 19:55:05 EDT 2025 Thu Apr 03 07:08:33 EDT 2025 Thu Apr 24 22:58:32 EDT 2025 Tue Jul 01 04:14:33 EDT 2025 Thu Nov 24 20:34:23 EST 2022 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | apoptosis STI571 K562 proliferation perillyl alcohol |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c1921-199f51c3c625c511b87106abbddbe4bcf317ac8ae566245ed329b52857483dc03 |
Notes | R965 R730.53 42-1679/R ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 15165112 |
PQID | 71959865 |
PQPubID | 23479 |
PageCount | 4 |
ParticipantIDs | wanfang_journals_tjykdxxb_e200401011 proquest_miscellaneous_71959865 pubmed_primary_15165112 crossref_citationtrail_10_1007_BF02830702 crossref_primary_10_1007_BF02830702 chongqing_backfile_9366655 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2004-00-00 |
PublicationDateYYYYMMDD | 2004-01-01 |
PublicationDate_xml | – year: 2004 text: 2004-00-00 |
PublicationDecade | 2000 |
PublicationPlace | China |
PublicationPlace_xml | – name: China |
PublicationTitle | Current medical science |
PublicationTitleAlternate | Journal of Zuazhong University of Science and Technology: Medical Edition |
PublicationTitle_FL | JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCES) |
PublicationYear | 2004 |
Publisher | Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022 |
Publisher_xml | – name: Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022 |
References | L He (BF02830702_CR6) 1997; 127 M W Deininger (BF02830702_CR1) 2000; 96 E A Ariazi (BF02830702_CR7) 1999; 59 P L. Crowell (BF02830702_CR2) 1999; 129 M B Sahin (BF02830702_CR5) 1999; 13 S S Clark (BF02830702_CR8) 2002; 16 X Sun (BF02830702_CR10) 2001; 97 D Hu (BF02830702_CR4) 2001; 14 J T Belanger (BF02830702_CR3) 1998; 3 J T Thiesing (BF02830702_CR9) 2000; 96 |
References_xml | – volume: 13 start-page: 1581 issue: 10 year: 1999 ident: BF02830702_CR5 publication-title: Lukemia doi: 10.1038/sj.leu.2401536 – volume: 14 start-page: 141 issue: 3 year: 2001 ident: BF02830702_CR4 publication-title: Clin Hematol J (Chinese) – volume: 96 start-page: 3343 year: 2000 ident: BF02830702_CR1 publication-title: Blood doi: 10.1182/blood.V96.10.3343 – volume: 3 start-page: 448 issue: 6 year: 1998 ident: BF02830702_CR3 publication-title: Altern Med Rev – volume: 97 start-page: 2008 year: 2001 ident: BF02830702_CR10 publication-title: Blood doi: 10.1182/blood.V97.7.2008 – volume: 127 start-page: 668 issue: 5 year: 1997 ident: BF02830702_CR6 publication-title: J Nutr doi: 10.1093/jn/127.5.668 – volume: 59 start-page: 1917 issue: 8 year: 1999 ident: BF02830702_CR7 publication-title: Cancer Res – volume: 129 start-page: 775S issue: 3 year: 1999 ident: BF02830702_CR2 publication-title: J. Nutr doi: 10.1093/jn/129.3.775S – volume: 16 start-page: 213 issue: 2 year: 2002 ident: BF02830702_CR8 publication-title: Leukemia doi: 10.1038/sj.leu.2402369 – volume: 96 start-page: 3195 issue: 9 year: 2000 ident: BF02830702_CR9 publication-title: Blood doi: 10.1182/blood.V96.9.3195 |
SSID | ssj0057624 ssib031263182 ssj0002039635 ssib051367596 ssib034325102 |
Score | 1.5726199 |
Snippet | The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for... R3; Summary: The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571on the proliferation and apoptosis of the cell line K562... |
SourceID | wanfang proquest pubmed crossref chongqing |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 41 |
SubjectTerms | Antineoplastic Agents - pharmacology Apoptosis - drug effects Benzamides Dose-Response Relationship, Drug Drug Synergism Fusion Proteins, bcr-abl - analysis HL-60 Cells Humans Imatinib Mesylate K562 Cells K562细胞 Monoterpenes - pharmacology Piperazines - pharmacology Pyrimidines - pharmacology STI571 单萜紫苏醇 细胞凋亡 细胞增殖 肿瘤抑制 |
Title | Effects of POH in Combination with STI571 on the Proliferation and Apoptosis of K562 Cells |
URI | http://lib.cqvip.com/qk/85740A/20041/9366655.html https://www.ncbi.nlm.nih.gov/pubmed/15165112 https://www.proquest.com/docview/71959865 https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200401011 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwHLXKduGCQHx1wLDELmjK1CR2kh67aVMYYiDRSoNLZDsOHxtJoYk09tfz-8V2kqqbBFyqNomc1u_VfnaenwnZy1mIMZUSyVt4GKjkJRHLPYV-Sujxc93uDfjuLEoX7PScn49GpwPXUlPLA3V947qS_0EVjgGuuEr2H5DtCoUD8B7whVdAGF7_CuPj3ozx4X26byzlMNQ1oLZTrB_nb3js20cC6Ma6RC-LuaDNaV1Wy7qyqSRvQabs41T-6hbNmjbi-ivuTrTu53ANBBbYz9UfdE-BbDfbyfcjuyTkU0_NtDFy3nakbh6CDRrNKEYHqwm0cK1qwDbYY5pIk3O10XJPnB8dE8nidhV2PYBw-aPFEPRJhBKx7706T6E7dYdsB3Hso71zEcxcrwzDKrPBsfuu61G19qbtJk2mGMzawAr9CQpiXbNsDETa9V5lIcovA2kyv0_uWXzozBDkARnp8iH5bMlBq4ICOei3kg7IQZEc1JCDwkcgB10jBwUsaUcOLATJQVtyPCKLk-P5UerZjTQ8hXF3aCYquK9CBYNdBT9Owih5Egkp81xqJlUBIlKoRGjQ9gHjOg-DqeRBwmOWhLmahI_JVlmV-imhfKKkYKHg0TRiwk8EV7oImGRTFgR5wcdkp6s2EGLqAuPFsmkIo2QOJ1-7esyUjaDHnVAuMxee3UMxJq-6a5cmeOXGq146ODJoF7ESRKmrZpXFmJqURHDPJwalvhSL8JjsWdgy-59eZfX33xf51ZXMNFIc8xf9nVsLeEbuGh8XTsg9J1v1r0a_AIlay12yPTs5PDzbbTn4Bzc0jEo |
linkProvider | Springer Nature |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effects+of+POH+in+combination+with+STI571+on+the+proliferation+and+apoptosis+of+K562+cells&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Chen%2C+Yan&rft.au=Hu%2C+Dong&rft.date=2004&rft.issn=1672-0733&rft.volume=24&rft.issue=1&rft.spage=41&rft_id=info:doi/10.1007%2FBF02830702&rft_id=info%3Apmid%2F15165112&rft.externalDocID=15165112 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg |